By G HossainPosted on November 13, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The back-heavy deal includes a $5 million upfront payment for two novel T cell engagers, though the companies have yet to disclose priority indications. Recently Launched Third Arc Turns to China for Cancer T Cell Engagers Post navigation Somnia Anesthesia Releases 2025 Anesthesia Labor Market StudyAbbVie Ends 11-Year Relationship With Calico, Lays Off 100+